Serotonergic-dopaminergic interactions: implications for hyperkinetic disorders
Gabay, S.
Advances in Experimental Medicine and Biology 133: 585-601
1981
ISSN/ISBN: 0065-2598 PMID: 6172019 Document Number: 172770
Document emailed within 1 workday
Related Documents
Gerstenbrand, F.; Poewe, W. 1987: Dopaminergic-peptidergic interactions in extrapyramidal disorders: a review of the clinical evidence Advances in Neurology 45: 67-73Masliah, E.; Rockenstein, E.; Veinbergs, I.; Mallory, M.; Hashimoto, M.; Takeda, A.; Sagara, Y.; Sisk, A.; Mucke, L. 2000: Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders Science 287(5456): 1265-1269
Soskić, V.; Joksimović, J. 1998: Bioisosteric approach in the design of new dopaminergic/serotonergic ligands Current Medicinal Chemistry 5(6): 493-512
Bluth, R.; Langnickel, R.; Ott, T. 1985: Modulation by dopaminergic and serotonergic systems of cholinergic interneurons in nucleus accumbens and striatum Polish Journal of Pharmacology and Pharmacy 37(6): 753-763
Yamawaki, S.; Lai, H.; Horita, A. 1983: Dopaminergic and serotonergic mechanisms of thermoregulation: mediation of thermal effects of apomorphine and dopamine Journal of Pharmacology and Experimental Therapeutics 227(2): 383-388
Quattrone, A.; Schettini, G.; Di Renzo, G.F.; Preziosi, P. 1979: Pharmacological evidence of an interaction between serotonergic and dopaminergic neurons in the control of prolactin secretion in male rats Archives Internationales de Pharmacodynamie et de Therapie 238(1): 42-49
Sulser, F. 1987: Serotonin-norepinephrine receptor interactions in the brain: implications for the pharmacology and pathophysiology of affective disorders Journal of Clinical Psychiatry 48 Suppl: 12-18
Akiyama, K.; Sato, M.; Kashihara, K.; Otsuki, S. 1982: Lasting changes in high affinity 3H-spiperone binding to the rat striatum and mesolimbic area after chronic methamphetamine administration: evaluation of dopaminergic and serotonergic receptor components Biological Psychiatry 17(12): 1389-1402
Robinson, S.E. 1984: Serotonergic-cholinergic interactions in blood pressure control in the rat Federation Proceedings 43(1): 21-24
Jørgensen, O.Sylvester. 2002: Hyperkinetic and attention disorders (DAMP) Ugeskrift for Laeger 164(40): 4627
György, L. 1979: Role of dopaminergic and GABA-ergic interactions in seizure susceptibility Archives Internationales de Pharmacodynamie et de Therapie 241(2): 280-286
El Ayadi, A.; Errami, M. 1999: Interactions between neomycin and cerebral dopaminergic and serotoninergic transmission in rats Therapie 54(5): 595-599
Sukhotina, N.K.; Konovalova, V.V.; Kryzhanovskaia, I.L.; Kupriianova, T.A. 2010: Efficacy of pantogam in the treatment of hyperkinetic disorders in children Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 110(12): 24-28
Iorio, L.C.; Barnett, A.; Leitz, F.H.; Houser, V.P.; Korduba, C.A. 1983: SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems Journal of Pharmacology and Experimental Therapeutics 226(2): 462-468
Bylund, D.B. 1981: Interactions of neuroleptic metabolites with dopaminergic, alpha adrenergic and muscarinic cholinergic receptors Journal of Pharmacology and Experimental Therapeutics 217(1): 81-86
Carlsson, A. 1977: Dopaminergic autoreceptors: background and implications Advances in Biochemical Psychopharmacology 16: 439-441
Sukhotina, N.K. 2009: Elaboration of a patient management protocol for Hyperkinetic disorders in children and adolescents Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 109(4): 43-49
Terleckyj, I.; Sonsalla, P.K. 1994: The sigma receptor ligand (+/-)-BMY 14802 prevents methamphetamine-induced dopaminergic neurotoxicity via interactions at dopamine receptors Journal of Pharmacology and Experimental Therapeutics 269(1): 44-50
Vetulani, J.; Byrska, B.; Reichenberg, K. 1979: Head twitches produced by serotonergic drugs and opiates after lesion of the mesostriatal serotonergic system of the rat Polish Journal of Pharmacology and Pharmacy 31(4): 413-423
Sellers, E.M.; Higgins, G.A.; Tomkins, D.M.; Romach, M.K.; Toneatto, T. 1991: Opportunities for treatment of psychoactive substance use disorders with serotonergic medications Journal of Clinical Psychiatry 52 Suppl: 49-54